1. The roles and therapeutic approaches of MSC-derived exosomes in colorectal cancer

   • Jie Yang
   • Liman Zhang

   Review Article 17 January 2022 Pages: 959 - 967

   

2. A strategic reflection for the management and implementation of CAR-T therapy in Spain: an expert consensus paper

   • N. Zozaya
   • J. Villaseca
   • A. Hidalgo-Vega

   Review Article Open access 08 January 2022 Pages: 968 - 980

   

3. Current status and future perspectives in HER2 positive advanced gastric cancer

   • G. Roviello
   • M. Catalano
   • L. Antonuzzo

   Review Article 29 January 2022 Pages: 981 - 996

   

4. Long non-coding RNAs involved in different steps of cancer metastasis

   • P. Suman
   • Y. Chhichholiya
   • A. Munshi

   Review Article 04 February 2022 Pages: 997 - 1013

   

5. Signaling pathways and their potential therapeutic utility in esophageal squamous cell carcinoma

   • L. K. Kadian
   • M. Arora
   • S. S. Chauhan

   Review Article 06 January 2022 Pages: 1014 - 1032

   

6. Expert consensus to optimize the treatment of elderly patients with luminal metastatic breast cancer

   • M. D. Torregrosa-Maicas
   • S. del Barco-Berrón
   • R. Gironés-Sarrió

   Special Article Open access 01 February 2022 Pages: 1033 - 1046

7. A high tumour-stroma ratio (TSR) in colon tumours and its metastatic lymph nodes predicts poor cancer-free survival and chemo resistance

   • M. T. A. Strous
   • T. K. E. Faes
   • A. P. de Bruïne

   Research Article 22 January 2022 Pages: 1047 - 1058

   

8. The inhibitory effect of LINC00261 upregulation on the pancreatic cancer EMT process is mediated by KLF13 via the mTOR signaling pathway

   • B. Li
   • S. Pang
   • Y. Zhou

   Research Article 23 January 2022 Pages: 1059 - 1072

   

9. IFN-γ affects pancreatic cancer properties by MACC1-AS1/MACC1 axis via AKT/mTOR signaling pathway

   • X.-Y. Shi
   • X.-L. Zhang
   • S.-Y. Qin

   Research Article 17 January 2022 Pages: 1073 - 1085

   

10. Roles of circ_0000135/miR-140-3p/PDZK1 network in cervical cancer

    • N. Wang
    • Y. Zheng
    • J. Q. Liu

    Research Article 23 January 2022 Pages: 1086 - 1099

    

11. Identification of immunophenotypes in esophageal squamous cell carcinoma based on immune gene sets

    • Danlei Song
    • Yongjian Wei
    • Yongning Zhou

    Research Article 31 January 2022 Pages: 1100 - 1114

    

12. MicroRNA-4463 facilitates the development of colon cancer by suppression of the expression of PPP1R12B

    • J. Tan
    • T. Lu
    • Y. Zhu

    Research Article 22 January 2022 Pages: 1115 - 1123

    

13. LncRNA ABHD11-AS1 promotes tumor progression in papillary thyroid carcinoma by regulating EPS15L1/EGFR signaling pathway

    • H. Lu
    • C. Zhu
    • Q. Wei

    Research Article 31 January 2022 Pages: 1124 - 1133

    

14. Characterization of the fecal microbiota in gastrointestinal cancer patients and healthy people

    • Ningning Li
    • Chunmei Bai
    • Xiaoyuan Li

    Research Article 15 February 2022 Pages: 1134 - 1147

    

15. Negative value of CD10⁻/CD34⁻ immunophenotype in pediatric leukemia and development of a related cell line model for investigating drug resistance

    • N. Aberuyi
    • S. Rahgozar

    Research Article 05 January 2022 Pages: 1148 - 1156

    

16. The mitochondrial DNA constitution shaping T-cell immunity in patients with rectal cancer at high risk of metastatic progression

    • P. A. Bousquet
    • S. Meltzer
    • A. H. Ree

    Research Article Open access 27 December 2021 Pages: 1157 - 1167

    

17. DAZAP1 overexpression promotes growth of HCC cell lines: a primary study using CEUS

    • J. J. Deng
    • G. P. Li
    • Y. Wang

    Research Article 29 January 2022 Pages: 1168 - 1176

    

18. Stereotactic radiosurgery for bone metastases in oligometastatic prostate cancer patients: DESTROY-2 clinical trial subanalysis

    • F. Deodato
    • D. Pezzulla
    • G. Macchia

    Research Article 04 January 2022 Pages: 1177 - 1183

    

19. Circulating myeloid-derived suppressors cells correlate with clinicopathological characteristics and outcomes undergoing neoadjuvant chemoimmunotherapy in non-small cell lung cancer

    • T. Wen
    • C. Su
    • Z. Liu

    Research Article 06 January 2022 Pages: 1184 - 1194

    

20. circRNA CRIM1 regulates the migration and invasion of bladder cancer by targeting miR182/Foxo3a axis

    • X. Y. Yu
    • C. Q. Ma
    • Y. H. Sheng

    Research Article 07 January 2022 Pages: 1195 - 1203

    

21. Pediatric medulloblastoma express immune checkpoint B7-H3

    • S. Li
    • G. C. Poolen
    • N. Bovenschen

    Brief Research Article Open access 05 January 2022 Pages: 1204 - 1208

    

22. Monitoring of RAS mutant clones in plasma of patients with RAS mutant metastatic colorectal cancer

    • A. Fernández Montes
    • E. Élez
    • E. Aranda

    Brief Research Article Open access 07 January 2022 Pages: 1209 - 1214

    

23. Letter to the editor regarding ‘Stereotactic radiosurgery for bone metastases in oligometastatic prostate cancer patients: DESTROY‑2 clinical trial subanalysis’

    • Cem Onal
    • Ezgi Oymak

    Correspondence 03 March 2022 Pages: 1215 - 1216

24. Reply to “Letter to the editor regarding ‘Stereotactic radiosurgery for bone metastases in oligometastatic prostate cancer patients: DESTROY-2 clinical trial subanalysis’”

    • Francesco Deodato
    • Donato Pezzulla
    • Gabriella Macchia

    Correspondence 19 March 2022 Pages: 1217 - 1218